Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

NYSE:CLVT - New York Stock Exchange, Inc. - JE00BJJN4441 - Common Stock - Currency: USD

4.84  0 (0%)

After market: 4.84 0 (0%)

Fundamental Rating

3

Taking everything into account, CLVT scores 3 out of 10 in our fundamental rating. CLVT was compared to 82 industry peers in the Professional Services industry. While CLVT is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CLVT.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CLVT had positive earnings in the past year.
In the past year CLVT had a positive cash flow from operations.
In the past 5 years CLVT always reported negative net income.
Each year in the past 5 years CLVT had a positive operating cash flow.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

CLVT has a Return On Assets of -5.81%. This is in the lower half of the industry: CLVT underperforms 77.22% of its industry peers.
With a Return On Equity value of -13.00%, CLVT is not doing good in the industry: 77.22% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.84%, CLVT is doing worse than 67.09% of the companies in the same industry.
CLVT had an Average Return On Invested Capital over the past 3 years of 1.83%. This is significantly below the industry average of 13.65%.
The last Return On Invested Capital (1.84%) for CLVT is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -5.81%
ROE -13%
ROIC 1.84%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.83%
ROIC(5y)1.31%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 9.16%, CLVT is in the better half of the industry, outperforming 68.35% of the companies in the same industry.
In the last couple of years the Operating Margin of CLVT has grown nicely.
CLVT has a Gross Margin of 66.00%. This is in the better half of the industry: CLVT outperforms 78.48% of its industry peers.
CLVT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.16%
PM (TTM) N/A
GM 66%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLVT is destroying value.
Compared to 1 year ago, CLVT has more shares outstanding
The number of shares outstanding for CLVT has been increased compared to 5 years ago.
CLVT has a worse debt/assets ratio than last year.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that CLVT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.30, CLVT is not doing good in the industry: 82.28% of the companies in the same industry are doing better.
CLVT has a debt to FCF ratio of 13.88. This is a negative value and a sign of low solvency as CLVT would need 13.88 years to pay back of all of its debts.
The Debt to FCF ratio of CLVT (13.88) is worse than 62.03% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that CLVT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.88, CLVT is doing worse than 69.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 13.88
Altman-Z -0.3
ROIC/WACC0.26
WACC7.12%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.87 indicates that CLVT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.87, CLVT is doing worse than 79.75% of the companies in the same industry.
CLVT has a Quick Ratio of 0.87. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLVT (0.87) is worse than 79.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CLVT have decreased strongly by -10.84% in the last year.
The Earnings Per Share has been growing slightly by 1.87% on average over the past years.
CLVT shows a decrease in Revenue. In the last year, the revenue decreased by -2.74%.
The Revenue has been growing by 21.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-10.84%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-8.7%
Revenue 1Y (TTM)-2.74%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-3.03%

3.2 Future

CLVT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.22% yearly.
The Revenue is expected to grow by 1.89% on average over the next years.
EPS Next Y-0.76%
EPS Next 2Y3.02%
EPS Next 3Y5.28%
EPS Next 5Y3.22%
Revenue Next Year-0.69%
Revenue Next 2Y0.75%
Revenue Next 3Y2.2%
Revenue Next 5Y1.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

CLVT is valuated cheaply with a Price/Earnings ratio of 6.54.
CLVT's Price/Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 91.14% of the companies in the same industry.
CLVT is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
CLVT is valuated cheaply with a Price/Forward Earnings ratio of 6.59.
Based on the Price/Forward Earnings ratio, CLVT is valued cheaper than 92.41% of the companies in the same industry.
CLVT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.54
Fwd PE 6.59
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLVT is valued cheaply inside the industry as 82.28% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLVT is valued cheaper than 91.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.56
EV/EBITDA 7.96
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.02%
EPS Next 3Y5.28%

0

5. Dividend

5.1 Amount

CLVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (2/21/2025, 8:10:05 PM)

After market: 4.84 0 (0%)

4.84

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners62.29%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner Change-0.61%
Market Cap3.44B
Analysts77.33
Price Target6.43 (32.85%)
Short Float %9.94%
Short Ratio8.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-5.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.91%
Min EPS beat(2)0.21%
Max EPS beat(2)1.61%
EPS beat(4)3
Avg EPS beat(4)2.13%
Min EPS beat(4)-1.33%
Max EPS beat(4)8.03%
EPS beat(8)7
Avg EPS beat(8)6.04%
EPS beat(12)11
Avg EPS beat(12)8.78%
EPS beat(16)14
Avg EPS beat(16)7.23%
Revenue beat(2)0
Avg Revenue beat(2)-3.17%
Min Revenue beat(2)-4.81%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.37%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)-0.95%
Revenue beat(8)1
Avg Revenue beat(8)-1.75%
Revenue beat(12)2
Avg Revenue beat(12)-1.74%
Revenue beat(16)3
Avg Revenue beat(16)-1.62%
PT rev (1m)-0.98%
PT rev (3m)-17.24%
EPS NQ rev (1m)-2.83%
EPS NQ rev (3m)-9.62%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-7.97%
Revenue NQ rev (1m)-2.03%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE 6.54
Fwd PE 6.59
P/S 1.34
P/FCF 10.56
P/OCF 5.32
P/B 0.67
P/tB N/A
EV/EBITDA 7.96
EPS(TTM)0.74
EY15.29%
EPS(NY)0.73
Fwd EY15.17%
FCF(TTM)0.46
FCFY9.47%
OCF(TTM)0.91
OCFY18.81%
SpS3.6
BVpS7.23
TBVpS-6.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -13%
ROCE 2.33%
ROIC 1.84%
ROICexc 1.9%
ROICexgc N/A
OM 9.16%
PM (TTM) N/A
GM 66%
FCFM 12.73%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.83%
ROIC(5y)1.31%
ROICexc(3y)1.89%
ROICexc(5y)1.35%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.31%
ROCE(5y)1.66%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 13.88
Debt/EBITDA 4.7
Cap/Depr 44.17%
Cap/Sales 12.56%
Interest Coverage 0.88
Cash Conversion 67.27%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z -0.3
F-Score6
WACC7.12%
ROIC/WACC0.26
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.84%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-8.7%
EPS Next Y-0.76%
EPS Next 2Y3.02%
EPS Next 3Y5.28%
EPS Next 5Y3.22%
Revenue 1Y (TTM)-2.74%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-3.03%
Revenue Next Year-0.69%
Revenue Next 2Y0.75%
Revenue Next 3Y2.2%
Revenue Next 5Y1.89%
EBIT growth 1Y-12.12%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9997.96%
EBIT Next 3Y376.67%
EBIT Next 5Y157.15%
FCF growth 1Y-34.41%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-13.11%
OCF growth 3Y25.93%
OCF growth 5Y40.62%